OBJECTIVE: To investigate changes in serum concentrations of the biochemical markers of brain damage S-100B and neuron-specific enolase (NSE) in ice hockey and basketball players during games. DESIGN: Descriptive clinical research. SETTING: Competitive games of the Swedish Elite Ice Hockey League and the Swedish Elite Basketball League. PARTICIPANTS: Twenty-six male ice hockey players (from two teams) and 18 basketball players (from two teams). INTERVENTIONS: None. MAIN OUTCOME MEASURES: S-100B and NSE were analyzed using two-site immunoluminometric assays. The numbers of acceleration/deceleration events were assessed from videotape recordings of the games. Head trauma-related symptoms were monitored 24 hours after the game using the Rivermead Post Concussion Symptoms Questionnaire. RESULTS: Changes in serum concentrations of S-100B (postgame - pregame values) were statistically significant after both games (ice hockey, 0.072 +/- 0.108 microg/L, P = 0.00004; basketball, 0.076 +/- 0.091 microg/L, P = 0.001). In basketball, there was a significant correlation between the change in S-100B (postgame-pregame values) and jumps, which were the most frequent acceleration/deceleration (r = 0.706, P = 0.002). For NSE, no statistically significant change in serum concentration was found in either game. For one ice hockey player who experienced concussion during play, S-100B was increased more than for the other players. CONCLUSIONS: S-100B was released into the blood of the players as a consequence of game-related activities and events. Analysis of the biochemical brain damage markers (in particular S-100B) seems to have the potential to become a valuable additional tool for assessment of the degree of brain tissue damage in sport-related head trauma and probably for decision making about returning to play.
OBJECTIVE: To investigate changes in serum concentrations of the biochemical markers of brain damage S-100B and neuron-specific enolase (NSE) in ice hockey and basketball players during games. DESIGN: Descriptive clinical research. SETTING: Competitive games of the Swedish Elite Ice Hockey League and the Swedish Elite Basketball League. PARTICIPANTS: Twenty-six male ice hockey players (from two teams) and 18 basketball players (from two teams). INTERVENTIONS: None. MAIN OUTCOME MEASURES: S-100B and NSE were analyzed using two-site immunoluminometric assays. The numbers of acceleration/deceleration events were assessed from videotape recordings of the games. Head trauma-related symptoms were monitored 24 hours after the game using the Rivermead Post Concussion Symptoms Questionnaire. RESULTS: Changes in serum concentrations of S-100B (postgame - pregame values) were statistically significant after both games (ice hockey, 0.072 +/- 0.108 microg/L, P = 0.00004; basketball, 0.076 +/- 0.091 microg/L, P = 0.001). In basketball, there was a significant correlation between the change in S-100B (postgame-pregame values) and jumps, which were the most frequent acceleration/deceleration (r = 0.706, P = 0.002). For NSE, no statistically significant change in serum concentration was found in either game. For one ice hockey player who experienced concussion during play, S-100B was increased more than for the other players. CONCLUSIONS:S-100B was released into the blood of the players as a consequence of game-related activities and events. Analysis of the biochemical brain damage markers (in particular S-100B) seems to have the potential to become a valuable additional tool for assessment of the degree of brain tissue damage in sport-related head trauma and probably for decision making about returning to play.
Authors: Paul McCrory; Willem H Meeuwisse; Mark Aubry; Robert C Cantu; Jiři Dvořák; Ruben J Echemendia; Lars Engebretsen; Karen Johnston; Jeffrey S Kutcher; Martin Raftery; Allen Sills; Brian W Benson; Gavin A Davis; Richard Ellenbogen; Kevin M Guskiewicz; Stanley A Herring; Grant L Iverson; Barry D Jordan; James Kissick; Michael McCrea; Andrew S McIntosh; David Maddocks; Michael Makdissi; Laura Purcell; Margot Putukian; Kathryn Schneider; Charles H Tator; Michael Turner Journal: J Athl Train Date: 2013 Jul-Aug Impact factor: 2.860
Authors: Linda Papa; Michelle M Ramia; Damyan Edwards; Brian D Johnson; Semyon M Slobounov Journal: J Neurotrauma Date: 2015-01-23 Impact factor: 5.269
Authors: Stefanie Schulte; Leslie W Podlog; J Jordan Hamson-Utley; Frederick G Strathmann; Heiko K Strüder Journal: J Athl Train Date: 2014 Nov-Dec Impact factor: 2.860
Authors: Keisuke Kawata; Charles Y Liu; Steven F Merkel; Servio H Ramirez; Ryan T Tierney; Dianne Langford Journal: Neurosci Biobehav Rev Date: 2016-05-12 Impact factor: 8.989
Authors: Matthew J Rogatzki; Scott E Soja; Colleen A McCabe; Ryanne E Breckenridge; Jeffrey L White; Julien S Baker Journal: Int J Immunopathol Pharmacol Date: 2016-07-07 Impact factor: 3.219